Education
About Us
Working with TipRanks
Follow Us
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
NYMXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.40
Previous CloseN/A
Volume2.20K
Average Volume (3M)11.36K
Market Cap
$9.45M
Enterprise Value$9.41M
Total Cash (Recent Filing)$70.00K
Total Debt (Recent Filing)$750.00K
Price to Earnings (P/E)―
Beta-358.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding94,540,140
10 Day Avg. Volume15,329
30 Day Avg. Volume11,361
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-1.49
Price to Sales (P/S)0.00
P/FCF Ratio-10.54
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-1.18K
Enterprise Value/Ebitda-0.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nymox Pharmaceutical News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
NYMXF FAQ
What was Nymox Pharmaceutical’s price range in the past 12 months?
Nymox Pharmaceutical lowest stock price was <$0.01 and its highest was $1.40 in the past 12 months.
What is Nymox Pharmaceutical’s market cap?
Nymox Pharmaceutical’s market cap is $9.45M.
When is Nymox Pharmaceutical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nymox Pharmaceutical’s earnings last quarter?
Currently, no data Available
Is Nymox Pharmaceutical overvalued?
According to Wall Street analysts Nymox Pharmaceutical’s price is currently Overvalued.
Does Nymox Pharmaceutical pay dividends?
Nymox Pharmaceutical does not currently pay dividends.
What is Nymox Pharmaceutical’s EPS estimate?
Nymox Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nymox Pharmaceutical have?
Nymox Pharmaceutical has 94,540,140 shares outstanding.
What happened to Nymox Pharmaceutical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nymox Pharmaceutical?
Currently, no hedge funds are holding shares in NYMXF
Company Description
Nymox Pharmaceutical
Nymox Pharmaceutical Corporation (NYMXF) is a biopharmaceutical company focused on the research and development of novel therapeutics for the treatment of unmet medical needs in the aging population. The company primarily operates in the biotechnology and pharmaceutical sectors. Its core products include investigational drugs aimed at treating benign prostatic hyperplasia (BPH) and other aging-related conditions, with a strong focus on its lead product candidate, NX-1207.
Technical Analysis
Cyclacel Pharmaceuticals
―
Alterity Therapeutics
―
SCYNEXIS
―
Brainstorm Cell Therapeutics
―
ESSA Pharma
―